DrugsControl Media Services
DrugsControl.org

News Detail

DCGI allows relabeling & re-stickering of drugs under Rule 104A (01-02-2023)

Mumbai, 1 Feb 2023: With reference to the re-stickering of price controlled scheduled drugs and National List of Essential Medicines (NLEM), the Drugs Controller General of India (DCGI) has issued a circular to the state drug controllers (SDCs) stating that it has no objection fo......
View Details

Source : Pharmabiz
re-stickering NLEM DCGI SDCs Rule 104A of Drugs Rules D Rules NPPA CDSCO Torrent Pharmaceuticals MRP

Related News